跳至主要内容
临床试验/NCT04937400
NCT04937400进行中(未招募)不适用

Delirium in Children Undergoing Stem Cell Transplantation: Epidemiology and Outcomes

Weill Medical College of Cornell University6 个研究点 分布在 2 个国家目标入组 1,040 人开始时间: 2021年7月12日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
1,040
试验地点
6
主要终点
Delirium incidence

研究概览

简要总结

Children undergoing stem cell transplants are at risk for delirium, a temporary change in thinking and behavior. This study will define delirium rates, risk factors, and outcomes. Our eventual goal is to reduce delirium in this population.

详细描述

Delirium -- defined as an acute change in awareness and cognition that occurs in the setting of an underlying illness -- is a common complication of hematopoietic stem cell transplantation (HSCT) in adults, with associated morbidity and mortality. This has never been studied in children, where risk factors may vary substantially from adults. The objectives of this study are: to define the epidemiology of delirium, and measure its effect on outcomes.

This prospective longitudinal cohort study will prospectively establish the incidence of delirium in 1000 children in the peri-transplant period, and identify modifiable risk factors that predispose to delirium development. This study will also define the effect of delirium on important clinical outcomes, including neurocognitive function. This study will be executed by a research consortium of five leading pediatric oncologic transplant centers in North America, in collaboration with the leading pediatric delirium research group in the United States.

This innovative proposal will leverage the combined experience of the pediatric delirium and HSCT teams to expand urgently needed delirium research into a unique and unstudied population. By reducing delirium rates, outcomes after pediatric HSCT can be optimized.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Age 0-21 years old
  • Admitted for purpose of stem cell transplant

排除标准

  • Age >21 years old
  • Admitted for reason other than stem cell transplant (example: late post-transplant complications).

结局指标

主要结局

Delirium incidence

时间窗: 1-50 days

Number of patients who develop delirium during the course of their transplant hospitalization

次要结局

  • Hospital length of stay(1-365 days)
  • Mortality rate(1-5 years)
  • Readmission rate(1-365 days)
  • Change in neurocognitive functioning as measured by the NIH Toolbox Cognition Battery(pre-transplant, 3 months after transplant, 12 months after transplant)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验